Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis
Binghua Zhou1, Lijun Li2, Yajing Li3
1Department of Spinal Surgery, Affiliated Longhua Central Hospital, Guangdong Medical University, Shenzhen 518110, Guangdong, China.
Abstract:
The long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) overexpression was found in various tumors and the dysregulated expression of SNHG12 contributed to multidrug resistance in non-small cell lung cancer. However, the role of SNHG12 in doxorubicin resistance of osteosarcoma is still unclear. In present study, we explored the function and underlying mechanism of SNHG12 on doxorubicin resistance in osteosarcoma. High expression of SNHG12 was associated with doxorubicin resistance and a poor overall survival in osteosarcoma. Furthermore, doxorubicin-resistant cells revealed a higher expression of SNHG12 compared with doxorubicin-sensitive cells. Moreover, dual luciferase reporter and RNA immunoprecipitation assays revealed that miR-320a targeted to SNHG12. Besides, knockdown of SNHG12 contributed to the upregulation of miR-320a and improved the sensitivity of doxorubicin. Additionally, miR-320a inhibited the expression of Myeloid cell leukemia 1 (MCL1). Finally, the results indicated that SNHG12 mediated doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
Insights
High expression of small nucleolar RNA host gene 12 (SNHG12) promotes doxorubicin resistance in osteosarcoma by inhibiting miR-320a, which targets MCL1. This finding offers a potential therapeutic target for overcoming drug resistance in osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA SNHG12 is overexpressed in various cancers and linked to multidrug resistance.
- The specific role of SNHG12 in doxorubicin resistance in osteosarcoma remains largely uncharacterized.
Purpose of the Study:
- To investigate the function and molecular mechanism of SNHG12 in doxorubicin resistance in osteosarcoma.
- To explore the potential of targeting the SNHG12/miR-320a/MCL1 axis for therapeutic intervention.
Main Methods:
- Analysis of SNHG12 expression in osteosarcoma tissues and cell lines.
- Dual luciferase reporter assays and RNA immunoprecipitation to confirm the interaction between SNHG12 and miR-320a.
- Assessment of doxorubicin sensitivity following SNHG12 knockdown and miR-320a mimic transfection.
Main Results:
- High SNHG12 expression correlated with doxorubicin resistance and poor survival in osteosarcoma patients.
- Doxorubicin-resistant osteosarcoma cells exhibited significantly higher SNHG12 levels.
- SNHG12 directly targeted miR-320a, and its knockdown led to miR-320a upregulation and increased doxorubicin sensitivity.
- miR-320a was found to inhibit the expression of Myeloid cell leukemia 1 (MCL1).
Conclusions:
- SNHG12 promotes doxorubicin resistance in osteosarcoma by sponging miR-320a, thereby upregulating MCL1 expression.
- The SNHG12/miR-320a/MCL1 axis represents a potential therapeutic target for overcoming doxorubicin resistance in osteosarcoma.
Related Concept Videos
Hypothalamic-Pituitary Axis
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
Parallel-axis Theorem
RNA Polymerase II Accessory Proteins
Moment of a Force About an Axis: Scalar
To better understand the concept of moment of force, consider the example of a cyclist riding a bicycle. When the cyclist applies force on...
Moment of a Force About an Axis: Vector
First, establish a coordinate system to understand how the moment of a force...


